714 related articles for article (PubMed ID: 9050749)
1. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
Gadek-Michalska A; Bugajski AJ; Bugajski J
J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
[TBL] [Abstract][Full Text] [Related]
4. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
5. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
Ochedalski T; Subburaju S; Wynn PC; Aguilera G
J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 (IL-1) type I receptors mediate activation of rat hypothalamus-pituitary-adrenal axis and interleukin 6 production as shown by receptor type selective deletion mutants of IL-1beta.
Van Dam AM; Malinowsky D; Lenczowski MJ; Bartfai T; Tilders FJ
Cytokine; 1998 Jun; 10(6):413-7. PubMed ID: 9632526
[TBL] [Abstract][Full Text] [Related]
8. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
9. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
[TBL] [Abstract][Full Text] [Related]
10. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
Wilson ME; Fisher J; Brown J
Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
[TBL] [Abstract][Full Text] [Related]
11. Exogenous IL-1beta induces its own expression, but not that of IL-6 in the hypothalamus and activates HPA axis and prolactin release.
Skurlova M; Stofkova A; Jurcovicova J
Endocr Regul; 2006 Dec; 40(4):125-8. PubMed ID: 17201586
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
Beishuizen A; Thijs LG
J Endotoxin Res; 2003; 9(1):3-24. PubMed ID: 12691614
[TBL] [Abstract][Full Text] [Related]
13. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclooxygenase inhibitors on the CRH-induced pituitary-adrenocortical activity during crowding stress.
Bugajski J; Gadek-Michalska A; Bugajski AJ
J Physiol Pharmacol; 2003 Mar; 54(1):99-108. PubMed ID: 12674222
[TBL] [Abstract][Full Text] [Related]
16. Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic - pituitary - adrenal axis.
Bugajski AJ; Thor P; Głód R; Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2003 Dec; 54(4):643-52. PubMed ID: 14726617
[TBL] [Abstract][Full Text] [Related]
17. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
18. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
19. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
20. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
